Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the women's health initiative observational study

Obesity

Volumn 18, Issue 9, 2010, Pages 1812-1820

  Chan, Kei Hang K ^a   Song, Yiqing ^b   Hsu, Yi Hsiang ^c,d   You, Nai Chieh Y ^a   F Tinker, Lesley ^e   Liu, Simin ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e USA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BLOOD; CASE CONTROL STUDY; ETHNOLOGY; FEMALE; GENETICS; GENOTYPE; HUMAN; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AGED; ALLELES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; E-SELECTIN; FATTY ACID-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LONGITUDINAL STUDIES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA;

EID: 77956094990     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.496     Document Type: Article

References (34)

1. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolicdiseases and potential as drug targets. Nat Rev Drug Discov 2008;7:489-503.
2. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS.The fatty acid-binding protein, aP2, coordinates macrophage cholesteroltrafficking and inflammatory activity. Macrophage expression of aP2 impactsperoxisome proliferator-activated receptor gamma and IkappaB kinaseactivities. J Biol Chem 2005;280:12888-12895.
3. Makowski L, Hotamisligil GS. The role of fatty acid binding proteins inmetabolic syndrome and atherosclerosis. Curr Opin Lipidol 2005;16:543-548.
4. Lapsys NM, Kriketos AD, Lim-Fraser M et al. Expression of genes involvedin lipid metabolism correlate with peroxisome proliferator-activated receptorgamma expression in human skeletal muscle. J Clin Endocrinol Metab2000;85:4293-4297.
5. Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins:emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol2002;13:141-147.
6. Cabré A, Lázaro I, Girona J et al. Fatty acid binding protein 4 is increasedin metabolic syndrome and with thiazolidinedione treatment in diabeticpatients. Atherosclerosis 2007;195:e150-e158.
7. Maeda K, Cao H, Kono K et al. Adipocyte/macrophage fatty acid bindingproteins control integrated metabolic responses in obesity and diabetes.Cell Metab 2005;1:107-119.
8. Ordovas JM. Identification of a functional polymorphism at the adiposefatty acid binding protein gene (FABP4) and demonstration of itsassociation with cardiovascular disease: a path to follow. Nutr Rev2007;65:130-134.
9. Yeung DC, Xu A, Cheung CW et al. Serum adipocyte fatty acid-bindingprotein levels were independently associated with carotid atherosclerosis.Arterioscler Thromb Vasc Biol 2007;27:1796-1802.
10. Hotamisligil GS, Johnson RS, Distel RJ et al. Uncoupling of obesity frominsulin resistance through a targeted mutation in aP2, the adipocyte fattyacid binding protein. Science 1996;274:1377-1379.
11. Scheja L, Makowski L, Uysal KT et al. Altered insulin secretion associated withreduced lipolytic efficiency in aP2-/-mice. Diabetes 1999;48:1987-1994.
12. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS.Improved glucose and lipid metabolism in genetically obese mice lackingaP2. Endocrinology 2000;141:3388-3396.
13. Liu S, Tinker L, Song Y et al. A prospective study of inflammatory cytokinesand diabetes mellitus in a multiethnic cohort of postmenopausal women.Arch Intern Med 2007;167:1676-1685.
14. Song Y, Manson JE, Tinker L et al. Circulating levels of endothelial adhesionmolecules and risk of diabetes in an ethnically diverse cohort of women.Diabetes 2007;56:1898-1904.
15. Design of the Women's Health Initiative clinical trial and observational study.The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
16. Anderson GL, Manson J, Wallace R et al. Implementation of the Women'sHealth Initiative study design. Ann Epidemiol 2003;13:S5-17.
17. Hsu YH, Niu T, Song Y et al. Genetic variants in the UCP2-UCP3 genecluster and risk of diabetes in the Women's Health Initiative ObservationalStudy. Diabetes 2008;57:1101-1107.
18. A haplotype map of the human genome. Nature 2005;437:1299-1320.
19. Wang L, Liu S, Niu T, Xu X. SNPHunter: a bioinformatic software forsingle nucleotide polymorphism data acquisition and management. BMCBioinformatics 2005;6:60.
20. Lee CC, You NC, Song Y et al. Relation of genetic variation in the genecoding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort. Clin Chem2009;55:351-360.
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization ofLD and haplotype maps. Bioinformatics 2005;21:263-265.
22. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocksin the human genome. Science 2002;296:2225-2229.
23. de Bakker PI, Yelensky R, Pe'er I et al. Efficiency and power in geneticassociation studies. Nat Genet 2005;37:1217-1223.
24. Tso AW, Xu A, Sham PC et al. Serum adipocyte fatty acid binding proteinas a new biomarker predicting the development of type 2 diabetes:a 10-year prospective study in a Chinese cohort. Diabetes Care2007;30:2667-2672.
25. Tuncman G, Erbay E, Hom X et al. A genetic variant at the fatty acid-bindingprotein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes,and cardiovascular disease. Proc Natl Acad Sci USA 2006;103:6970-6975.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practicaland powerful approach to multiple testing. J R Stat Soc Series B Methodol1995;57:289-300.
27. Song Y, You NC, Hsu YH et al. Common genetic variation in calpain-10gene (CAPN10) and diabetes risk in a multi-ethnic cohort of Americanpostmenopausal women. Hum Mol Genet 2007;16:2960-2971.
28. Song Y, Hsu YH, Niu T et al. Common genetic variants of the ion channeltransient receptor potential membrane melastatin 6 and 7 (TRPM6 andTRPM7), magnesium intake, and risk of type 2 diabetes in women. BMCMed Genet 2009;10:4.
29. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest2005;115:1111-1119.
30. Xu A, Wang Y, Xu JY et al. Adipocyte fatty acid-binding protein is a plasmabiomarker closely associated with obesity and metabolic syndrome.Clin Chem 2006;52:405-413.
31. Prinsen CF, de Bruijn DR, Merkx GF, Veerkamp JH. Assignment of thehuman adipocyte fatty acid-binding protein gene (FABP4) to chromosome8q21 using somatic cell hybrid and fluorescence in situ hybridizationtechniques. Genomics 1997;40:207-209.
32. Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasianpopulation: a new marker of metabolic syndrome Eur J Clin Invest2006;36:621-625.
33. Boulbou MS, Koukoulis GN, Makri ED et al. Circulating adhesionmolecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol2005;98:39-44.
34. Lander ES, Schork NJ. Genetic dissection of complex traits. Science1994;265:2037-2048.